Our Firm is currently representing a number of Xarelto lawsuit plaintiffs in the federal proceeding, and we are pleased that his litigation is moving forward.
New York, New York (PRWEB) April 11, 2015
The federal court overseeing hundreds of Xarelto lawsuits (http://www.xareltolawsuit2015.com/)
filed on behalf of individuals who were allegedly harmed by the blood thinner convened its most recent Status Conference on April 1st. According to Minutes issued by the U.S. District Court, Eastern District of Louisiana, matters discussed included the Court’s efforts to coordinate with state Xarelto litigations. The Minutes also noted that the parties are continuing to meet and confer on a number of issues, including document production and the submission of a proposed Preservation Order. (In Re: Xarelto Products Liability Litigation, No. 2592)
“Our Firm is currently representing a number of Xarelto lawsuit plaintiffs in the federal proceeding, and we are pleased that this litigation is moving forward. The Courts’ efforts to coordinate with Xarelto litigations underway on the state level will allow claims to continue to progress in an efficient manner, and help preserve the resources of the courts, parties and witnesses,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices and drugs. The Firm is actively filing Xarelto lawsuits in U.S. courts on behalf of individuals who allegedly suffered a life-threatening internal bleeding episode, a stroke, deep vein thrombosis or pulmonary embolism due to their use of this blood thinner.
Nationwide Xarelto Litigation
Court records indicate that more than 500 Xarelto lawsuits are currently pending in courts nationwide. This includes nearly 300 claims that have filed in the Eastern District of Louisiana, where all federal lawsuits involving the blood thinner have been consolidated for the purposes of pretrial proceedings. More than 180 additional cases have been consolidated in a mass tort litigation currently underway in Pennsylvania’s Philadelphia Court of Common Pleas. (In Re: Xarelto Litigation, Case ID 150102349)
According to court documents, all of the Xarelto lawsuits pending in these proceedings involve similar allegations regarding the medication’s potential to cause uncontrollable internal bleeding and other serious side effects, including strokes, deep vein thrombosis and pulmonary embolism. Plaintiffs further allege that the manufacturers of Xarelto were wrong to market the blood thinner as a superior alternative to warfarin, an anticoagulant that has been on the market for decades. Among other things, they point out that bleeding associated with warfarin can be stopped via the administration of vitamin K, while there is currently no approved antidote to stop Xarelto bleeding.
Individuals who allegedly experienced internal bleeding and other complications related to Xarelto may be entitled to compensation or the medical bills and other damages. Learn more about filing a Xarelto lawsuit by visiting Bernstein Liebhard LLP’s website, or by calling 800-511-5092 to schedule a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP